A 12-Week Study in Asthmatic Children Ages 6 to <12 Years, Investigating the Efficacy and Safety of Symbicort pMDI 80/2.25 μg and Symbicort pMDI 80/4.5 μg, Compared With Budesonide pMDI 80 μg
Clinical trial NCT02091986 · COMPLETED
Trial details
- NCT number
- NCT02091986
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-04-01
- Primary completion
- 2016-04-01
- Enrollment
- 882
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.